Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2, Open-Label, Single-Arm Study of Lirafugratinib in Patients With Previously Treated, Unresectable, Locally Advanced or Metastatic Solid Tumors (Excluding Cholangiocarcinoma) With FGFR2 Fusion or Rearrangement

The goal of this clinical trial is to evaluate if lirafugratinib is efficacious and safe to treat adult patients with previously treated, unresectable, locally…

FGFR2 Gene Fusion/RearrangementOther Solid Tumors, Adult

Elevar TherapeuticsNCT07359820